Greetings

Blumenthal 2004 Lyme Hearing Transcript:

http://www.cslib.org/attygenl/health/0129lyme.pdf CDC's Paul Mead starts on page 258 of the .pdf.

Mead said he would make it clear that the diagnostic standard for Lyme is not to be used for diagnosis on the CDC's website.

He never did.

Then a year later (Feb 11, 2005), CDC posted on their website that you had to have a positive ELISA in order to have a positive Western Blot in order to be eligible for treatment of Lyme, when we know the first step, the ELISA, only detects the inflammatory or the Steere's Haplotype kind of Lyme. (See Chp3 of Cryme Disease on what Steere did in Europe)

So, CDC's Paul Mead bullshitted the CT Attorney General, and bullshit they do, to this day, and refuse to admit that the Allen Steere kind of Lyme is extraordinary. We think they are protecting their own staff from criminal investigation and prosecuting for lying about Lyme to profiteer, personally, which many of them are doing.

--------------------------------------------------------

How "Lyme disease" - the blood test definition, is scientific fraud.

INTRO

http://actionlyme.org/USDOJ_COMPLAINT_RICO.htm (racketeering and fraud)

Yale autopsy of the baby who died from the congenital Lyme brain damage.

1) Those named in the RICO complaint know how to detect Lyme disease; the CDC is complicit in this fraud; there are conflicts of interest, they deliberately conspired to hide real data,

2) Those named in the RICO complaint know we are very sick because these criminals themselves discovered the valid markers of disease, Lyme is a permanent brain infection, as are all borrelioses

3) Those named in the RICO complaint tried to discredit Lyme activists, intimidate Lyme-treating physicians, and fraudulently claim that the "bad guys" were being stalked by Lyme "terrorists" (Steere, Klempner, Gauvin), when the reverse was true..

4) Those named in the Lyme RICO complaint know that LYMErix never worked. They do not want Lyme to be detected because then it would then have to be treated and insurance companies do not want to be for this treatment.

5) A blood testing standard was invented around a vaccine and blood testing monopoly. Why OspA and B were left out of the blood testing (serodiagnostic) standard. The Monopoly on Lyme Testing

Conspiracy to commit fraud:   Edward McSweegan and Durland Fish conspire to send the Lyme Foundation "a bogus article" and discredit them, because McSweegan and Fish wanted to run a totally bogus vaccine trial, and the Forschner's discoveries about 9 hour dissemination of Lyme disease after tick attachment would have interfered with the vaccine protocol of not treating on tick attachment, but waiting for the Lyme rash to show up, first... but Dattwyler says to FDA: "Treat on tick bite to prevent brain invasion"



Not reporting adverse events in the vaccine trial:

Yale's Robert Schoen publishing in a book published in 1998, before LYMErix was even approved by the FDA, that MDs should blow off LYMErix victims, but that if they MUST bother to test for Lyme to see if LYMErix failed, the MDs should send the blood to the Yale RICO lab, L2 Diagnostics, since they, L2 Diagnostics and Imugen, were to be the only two labs in the country allowed to used the patented RICO method, where OspA and B are left out of the diagnostic standard, because, in fact, one cannot read Western Blots in LYMErix vaccinated people due to the Blot smudging.

    This also means that both of the two vaccine trials were fraudulent.
    'Were SCIENTIFIC FRAUD.
    ImmuLyme reported 92% safety and accuracy and Yale reported 76% safety and accuracy, despite not being able to tell at all whether or not OspA vaccination prevented Lyme. They had no intention of telling anyone that these were 100% fraudulent vaccine trials right from the start.

http://www.whale.to/m/lymerix8.html "Big Pharma Takes on the Wrong Little Osp" - 2001 FDA meeting as a result of adverse events not reported to the FDA and SmithKline.

Lewis Bull: Vijay Sikand blows him off as regards adverse events to LymeRIX.

Myself giving an explainer to the FDA on how LymeRIX wasn't qualified with a valid standard, was not shown to be a vaccine, and no one agreed with Steere's standard http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2_11.pdf

The CDC's first Lyme test: Changing and expanding IgM and IgG antibodies is indicative of ongoing infection:   PubMed ID 3531237, by Allen Steere

This becomes the CDC's 1990 Lyme test, the Steere Publication 3531237

Hiding the bad data: The Schoen and Fikrig chapter in Rahn and Evans In the chapter 9 of this textbook, Schoen and Fikrig recommend not to do testing on adverse events vaccinees- anticipating them, even before the vaccine was approved. MOTION TO COMPEL, September 29, 2005

CDC's Complicity in the Lyme FRAUD.

CDC and Gary Wormser have known what DNA primers to use to detect Borrelia in any human sample, including blood, since 1992, but these have never yet been used in any human treatment or any other aspect of the study and detection of Lyme disease: http://www.pubmedcentral.gov/picrender.fcgi?artid=270592&blobtype=pdf

SmithKline's Yves Lobet has known since knows what DNA primers to use to find borreliosis- They aren't the Osps, and they especially are not OspA (LYMErix): 1356932 Borrelia specific flagellin and HSPs

CDC Bullshitting CT AG Richard Blumenthal

    1) http://www.hhs.gov/asl/testify/t040129.html    First they say "There is no substitute for sound clinical judgment."   -CDC's Paul Mead to AG Richard Blumenthal   SEE PAGES STARTING on 258 of the .pdf

    2) Then they say that a positive test for Lyme is required: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5405a6.htm

CDC Says here: http://www.cdc.gov/ncidod/dvbid/lyme/ld_humandisease_diagnosis.htm

that the ELISA is very sensitive. It is not. It misses 85% of the cases of Lyme.

"1) The first step uses an ELISA or IFA test. These tests are designed to be very “sensitive,” meaning that almost everyone with Lyme disease, and some people who don’t have Lyme disease, will test positive. If the ELISA or IFA is negative, it is highly unlikely that the person has Lyme disease, and no further testing is recommended. If the ELISA or IFA is positive or indeterminate (sometimes called "equivocal"), a second step should be performed to confirm the results."

The ELISA first step test was intended to miss all cases of Lyme except late Lyme arthritis, where the knee is actually swollen. The only false positives come from Rheumatoid Arthritis.

This web page says:   "Health-care providers are reminded that a diagnosis of Lyme disease should be made after evaluation of a patient's clinical presentation and risk for exposure to infected ticks, and, if indicated, after the use of validated laboratory tests."

CDC promised AG Richard Blumenthal they would update their website to reveal that this standard was NOT to be used for diagnostic purposes, but the CDC did the opposite: They discredited all the other labs, and said this own standard for testing was "valid," when they knew this to not be true:

Blumenthal 2004 Lyme Hearing Transcript:: http://www.cslib.org/attygenl/health/0129lyme.pdf

Blumenthal May '05 Lyme Conference Video: http://autoimmunityresearch.org/photos/blumenthal.ram

The CDC's World Patents for Borreliosis, demonstrating that they know there are different forms of this disease, because they used genetically engineered mice to represent the arthritis-prone and the neuroborreliosis-prone forms of Lyme disease:

http://v3.espacenet.com/family?DB=EPODOC&IDX=WO9324145&F=8&OREQ=0&textdoc=TRUE

That is, "MHC-restricted" means Major Histocompatibility Complex (or tissue-type) restricted antibodies.

That is, the CDC knows that some people have arthritis, some will have neuroborreliosis, and some have the immune incompetent form of the disease. See the Home Page of this website regarding HLA-DQB1*0602 and Klempner, and Justin Radolf and toll-like receptors.

What that all means is that this lipoprotein type, OspA, turns off the antibody response in a known mechanism in some people.   The HLA molecules downregulate, basically.

Klempner said neuroborreliosis patients have a significant representation in the MS, Lupus, and narcolepsy haplotype (as did Roland Martin of the NINDS). Then he more recently said there was no such relationship. YOU DECIDE.

"The CDC is a disgrace. It is a corrupt organization," said Stephen A. Sheller, a Philadelphia attorney who has sued vaccine makers for what he says were bad vaccines. "The drug companies have them on their payroll."

CDC's Lyme test, tested in the field, by Gary Wormser PubMed # 308100

Igenex's Nick Harris saying nearly the same thing: http://www.igenex.com/labtest.htm

- - - - - - -

Yale's central participation in this huge medical scam:

Yale's 1993, patented test for Lyme, which is early, accurate (17/18), and specific and therefore the only validated test for Lyme disease: PubMed # 1894359 (developed in 1991)

Yale's patent for that 94.4% accurate test for Lyme: 5618533 Dec 10, 1993

Yale's LYMErix patent, applied for in Oct 1994, 5747294

Yale explains how LYMErix won't work, for days later, (Oct 11, 1994) and shouldn't be used on wild mice: 7729870

"Selection pressure" is what relapsing fever borrelia, basically, do. They change surface components to escape antibody attack.

Later, in 1994, CDC left these IgM antibodies basically out of the serodiagnostic standard, which is the CDC's clear participation in this Lyme disease FRAUD.

Yale autopsy of the baby who died from the congenital Lyme brain damage

UN Human Rights Complaint, April, 2003   Yale staff explaining how this very serious permanent brain and nervous system infection is actually imaginary.

Lyme physician and Lyme patient harassment.

Stalking Steere (a bunch of baloney).

Stalking Klempner (more baloney)

Stalking Gauvin (more baloney)

The Markers of Illness.

A) The Lyme fraud perps say we are "crazy" and don't have a real disease. That is, the very same people who determined we have a real illness,via the valid scientific, objective testing, later said we don't have these valid markers of disease . In the RI Tick Borne Diseases Management Plan, see the second half for the markers of disease- and who wrote them or identified them (Sigal, Klempner, Pachner, Halperin...)

Pathologies Index. Click on the "X" to bring you up to date on whether or not that marker has been found in that illness.

B) Here is Pam3Cys, which is what is unique about OspA (LymeRIX): Immune suppression/dysregulation.

Inasmuch as in some people this type of lipoprotein is inflammatory, in others, it basically shuts off the immune system response to it (we become tolerized to it).

C) Here is Corixa and SmithKline now joined as one company, creating allergy vaccines based on what they learned about OspA, represented in *fungal* antigens like pam3cys/OspA/mycobacterial lipopeptides.:   http://www.corixa.com/default.asp?pid=products

THAT IS, people with chronic Lyme, or post-LymeRIX syndrome are immune suppressed, particularly as regards mycoplasmal and mycobacterial infections, but also as regards all infections, because as you can see, Yale is also now interested in the damage they have done activating Epstein-Barr:

http://www.google.com/search?hl=en&q=Yale+and+epstein-Barr+fikrig&btnG=Google+Search

'Which was what Paul Duray noted in 1992 about how lymphocytes of chronic Lyme patients looked, as explained by Duray in Steve Schutzer's 1992 book, "Lyme disease, Molecular and Immunological Approaches."



Lyme is a borreliosis. That means, it is just one type of many borrelioses. To verify, use the taxonomy database, and see how many strains of borrelia have been identified.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=taxonomy

Type in "borrelia"

    Click on the word.

            See how many strains there are.

            See how many strains there are just in California (the CA-XXX strains).

STARI is a bovine borreliosis.

J Clin Microbiol. 2001 Feb;39(2):494-7.

Lone star tick-infecting borreliae are most closely related to the agent of bovine borreliosis.

    Rich SM, Armstrong PM, Smith RD, Telford SR 3rd.

   Division of Infectious Disease, Tufts University School of Veterinary Medicine, North Grafton, Massachusetts, USA.

     Although Borrelia theileri, the agent of bovine borreliosis, was described at the turn of the century (in 1903), its relationship with borreliae causing Lyme disease or relapsing fever remains undescribed. We tested the previously published hypothesis that spirochetes infecting Lone Star ticks (Amblyomma americanum) may comprise B. theileri by analyzing the 16S ribosomal DNAs (rDNAs) and flagellin genes of these spirochetes. B. theileri, the Amblyomma agent, and B. miyamotoi formed a natural group or clade distinct from but most closely related to that of the relapsing fever spirochetes. B. theileri and the Amblyomma agent were 97 and 98% similar at the nucleotide level within the analyzed portions of the 16S rDNA and the flagellin gene respectively, suggesting a recent divergence. The agent of bovine borreliosis might be explored as a surrogate antigen for the as-yet-uncultivatable Amblyomma agent in studies designed to explore the etiology of a Lyme disease-like infection associated with Lone Star ticks.

     PMID: 11158095 [PubMed - indexed for MEDLINE]